Search by Drug Name or NDC

    NDC 55150-0332-01 Oxaliplatin 5 mg/mL Details

    Oxaliplatin 5 mg/mL

    Oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is OXALIPLATIN.

    Product Information

    NDC 55150-0332
    Product ID 55150-332_414e3206-0454-4cf2-847f-4d035b49b532
    Associated GPIs 21100028002030
    GCN Sequence Number 059163
    GCN Sequence Number Description oxaliplatin VIAL 100MG/20ML INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 24701
    HICL Sequence Number 016687
    HICL Sequence Number Description OXALIPLATIN
    Brand/Generic Generic
    Proprietary Name Oxaliplatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxaliplatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name OXALIPLATIN
    Labeler Name Eugia US LLC
    Pharmaceutical Class Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205529
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0332-01 (55150033201)

    NDC Package Code 55150-332-01
    Billing NDC 55150033201
    Package 1 VIAL in 1 CARTON (55150-332-01) / 20 mL in 1 VIAL
    Marketing Start Date 2017-09-21
    NDC Exclude Flag N
    Pricing Information N/A